HIVEP1

Across TCGA pan-cancer cohorts, HIVEP1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated HIVEP1 data layer compared with 24 for mass-spec protein and 11 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher HIVEP1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated HIVEP1 expression acts as an unfavorable survival marker.

PDAC and HNSC are the cancer types where HIVEP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	All	0.183	0.687	.003	26	view →
HNSC	DFS	Median	IV	0.486	0.908	.017	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

HIVEP1–PDAC (OS)

Open the PDAC breakdown →